arrow
C

Chigusa Morizane

Department of Hepatobiliary and Pancreatic Oncology
H指数:49
被引数:9,184

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and safety of peptide radionuclide therapy with 177Lu-DOTATATE in Japanese patients with advanced neuroendocrine neoplasm: a multicenter retrospective study (JON2203-N)

177Lu-DOTATATE肽受体放射性核素治疗在日本晚期神经内分泌肿瘤患者中的疗效与安全性:一项多中心回顾性研究(JON2203-N)

2026-03-230
PRE
FGFR2 Fusions or Rearrangements in Young Intrahepatic and Perihilar Cholangiocarcinoma Patients: Key Genetic Insights From a Pan-Asian Study

FGFR2融合或重排在年轻肝内及肝门部胆管癌患者中的关键遗传学见解:一项泛亚洲研究

2025-09-160
OAAI
Outcomes of FOLFIRINOX versus Gemcitabine plus nab-Paclitaxel in Patients with Early Recurrent Pancreatic Cancer after Adjuvant S-1 Treatment: A propensity Score-matched Analysis

FOLFIRINOX与吉西他滨联合nab-紫杉醇在S-1辅助治疗后早期复发性胰腺癌患者中的疗效比较:一项倾向性评分匹配分析

2025-08-300
PRE
Clinical significance and efficacy of endoscopic ultrasound-guided tissue acquisition for para-aortic lymph node metastasis

超声内镜引导下腹主动脉旁淋巴结转移组织采集的临床意义及疗效分析

2025-03-010
OA
Multicenter observational study to characterize fibroblast growth factor receptor 2 fusions or rearrangements in patients with advanced/metastatic cholangiocarcinoma
2025-02-170
OAAI
Metal stent versus plastic stent in endoscopic ultrasound-guided hepaticogastrostomy for unresectable malignant biliary obstruction: Large single-center retrospective comparative study
2024-11-150
PRE
Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1) : updated overall survival from a randomised phase 3 study
2024-08-0115
PRE
The SCRUM-MONSTAR Cancer-Omics Ecosystem: Striving for a Quantum Leap in Precision Medicine

Scrum-monstar癌症组学生态系统: 努力实现精准医学的飞跃

2024-07-161
OAAI
Efficacy of endoscopic ultrasound-guided gastroenterostomy using self-expandable metallic stent for afferent loop syndrome: A single-center retrospective study
2024-06-070
PRE
Diagnostic performance of EUS-guided tissue acquisition for solid pancreatic lesions ≤10 mm
2024-04-051
OAAI
The impact of rare cancer and early-line treatments on the bene fi t of comprehensive genome pro fi ling-based precision oncology
2024-04-012
OAAI
Clinical development of a blood biomarker using apolipoprotein-A2 isoforms for early detection of pancreatic cancer
2024-01-231
OAAI
Identification of activity-based biomarkers for early-stage pancreatic tumors in blood using single-molecule enzyme activity screening
2024-01-013
OAAI